- Home
- NBR vs TECX Comparison
NBR vs TECX Comparison
Compare NBR & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBR
- TECX
- Stock Information
- Founded
- NBR 1952
- TECX 2019
- Country
- NBR Bermuda
- TECX United States
- Employees
- NBR N/A
- TECX N/A
- Industry
- NBR Oil & Gas Production
- TECX
- Sector
- NBR Energy
- TECX
- Exchange
- NBR Nasdaq
- TECX Nasdaq
- Market Cap
- NBR 417.7M
- TECX 334.4M
- IPO Year
- NBR N/A
- TECX 2018
- Fundamental
- Price
- NBR $31.81
- TECX $20.78
- Analyst Decision
- NBR Hold
- TECX Buy
- Analyst Count
- NBR 8
- TECX 6
- Target Price
- NBR $44.50
- TECX $78.67
- AVG Volume (30 Days)
- NBR 534.9K
- TECX 239.6K
- Earning Date
- NBR 07-29-2025
- TECX 08-13-2025
- Dividend Yield
- NBR N/A
- TECX N/A
- EPS Growth
- NBR N/A
- TECX N/A
- EPS
- NBR N/A
- TECX N/A
- Revenue
- NBR $2,932,608,000.00
- TECX N/A
- Revenue This Year
- NBR $13.65
- TECX N/A
- Revenue Next Year
- NBR $5.53
- TECX N/A
- P/E Ratio
- NBR N/A
- TECX N/A
- Revenue Growth
- NBR N/A
- TECX N/A
- 52 Week Low
- NBR $23.27
- TECX $13.70
- 52 Week High
- NBR $105.96
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- NBR 55.09
- TECX 48.58
- Support Level
- NBR $27.33
- TECX $19.13
- Resistance Level
- NBR $31.73
- TECX $21.46
- Average True Range (ATR)
- NBR 2.04
- TECX 1.24
- MACD
- NBR -0.03
- TECX 0.03
- Stochastic Oscillator
- NBR 51.62
- TECX 65.50
About NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.